ALC
Price
$78.76
Change
-$1.45 (-1.81%)
Updated
Dec 11 closing price
Capitalization
38.71B
81 days until earnings call
Intraday BUY SELL Signals
COO
Price
$82.11
Change
+$1.37 (+1.70%)
Updated
Dec 11 closing price
Capitalization
16.09B
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALC vs COO

Header iconALC vs COO Comparison
Open Charts ALC vs COOBanner chart's image
Alcon
Price$78.76
Change-$1.45 (-1.81%)
Volume$2.43M
Capitalization38.71B
Cooper Companies (The)
Price$82.11
Change+$1.37 (+1.70%)
Volume$2.55M
Capitalization16.09B
ALC vs COO Comparison Chart in %
ALC
Daily Signal:
Gain/Loss:
COO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALC vs. COO commentary
Dec 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a StrongBuy and COO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 13, 2025
Stock price -- (ALC: $78.76 vs. COO: $82.11)
Brand notoriety: ALC and COO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALC: 112% vs. COO: 87%
Market capitalization -- ALC: $38.71B vs. COO: $16.09B
ALC [@Pharmaceuticals: Other] is valued at $38.71B. COO’s [@Pharmaceuticals: Other] market capitalization is $16.09B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $194.04B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALC’s FA Score shows that 0 FA rating(s) are green whileCOO’s FA Score has 0 green FA rating(s).

  • ALC’s FA Score: 0 green, 5 red.
  • COO’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALC and COO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALC’s TA Score shows that 4 TA indicator(s) are bullish while COO’s TA Score has 6 bullish TA indicator(s).

  • ALC’s TA Score: 4 bullish, 5 bearish.
  • COO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, COO is a better buy in the short-term than ALC.

Price Growth

ALC (@Pharmaceuticals: Other) experienced а -0.29% price change this week, while COO (@Pharmaceuticals: Other) price change was +6.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.89%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was +2.95%.

Reported Earning Dates

ALC is expected to report earnings on Mar 03, 2026.

COO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-0.89% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALC($38.7B) has a higher market cap than COO($16.1B). COO has higher P/E ratio than ALC: COO (43.91) vs ALC (37.50). ALC YTD gains are higher at: -7.221 vs. COO (-10.682). ALC has higher annual earnings (EBITDA): 2.74B vs. COO (1.09B). ALC has more cash in the bank: 1.41B vs. COO (125M). COO has less debt than ALC: COO (2.48B) vs ALC (5.25B). ALC has higher revenues than COO: ALC (10B) vs COO (4.05B).
ALCCOOALC / COO
Capitalization38.7B16.1B240%
EBITDA2.74B1.09B252%
Gain YTD-7.221-10.68268%
P/E Ratio37.5043.9185%
Revenue10B4.05B247%
Total Cash1.41B125M1,126%
Total Debt5.25B2.48B212%
FUNDAMENTALS RATINGS
ALC vs COO: Fundamental Ratings
ALC
COO
OUTLOOK RATING
1..100
7121
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
8383
PRICE GROWTH RATING
1..100
5747
P/E GROWTH RATING
1..100
4064
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALC's Valuation (77) in the Hospital Or Nursing Management industry is in the same range as COO (77) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.

ALC's Profit vs Risk Rating (65) in the Hospital Or Nursing Management industry is somewhat better than the same rating for COO (100) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than COO’s over the last 12 months.

ALC's SMR Rating (83) in the Hospital Or Nursing Management industry is in the same range as COO (83) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.

COO's Price Growth Rating (47) in the Medical Specialties industry is in the same range as ALC (57) in the Hospital Or Nursing Management industry. This means that COO’s stock grew similarly to ALC’s over the last 12 months.

ALC's P/E Growth Rating (40) in the Hospital Or Nursing Management industry is in the same range as COO (64) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALCCOO
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
50%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
56%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
58%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
51%
Advances
ODDS (%)
Bullish Trend 10 days ago
58%
Bullish Trend 3 days ago
58%
Declines
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 15 days ago
60%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
67%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
ALC
Daily Signal:
Gain/Loss:
COO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WTID10.700.35
+3.36%
MicroSectors™ Energy -3X Invrs Lvrgd ETN
SARK29.240.38
+1.32%
Tradr 1X Short Innovation Daily ETF
BXSY15.270.12
+0.82%
Bexil Investment Trust
ECAT15.790.09
+0.57%
BlackRock ESG Capital Allocation Term Trust
SPBX27.410.02
+0.07%
AllianzIM 6 Month Buffer10 Allocation ETF

ALC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALC
1D Price
Change %
ALC100%
-1.81%
SYK - ALC
54%
Loosely correlated
-0.23%
A - ALC
54%
Loosely correlated
-0.42%
COO - ALC
53%
Loosely correlated
+1.70%
DHR - ALC
53%
Loosely correlated
+0.85%
TMO - ALC
53%
Loosely correlated
+0.89%
More

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+1.70%
ALC - COO
53%
Loosely correlated
-1.81%
A - COO
50%
Loosely correlated
-0.42%
DHR - COO
46%
Loosely correlated
+0.85%
RGEN - COO
45%
Loosely correlated
-1.31%
SYK - COO
44%
Loosely correlated
-0.23%
More